Insights

Casual Nexus – Episode Three: Sterile Drug Product Manufacturing During a Global Pandemic

icons/content-types/video webinar

Drug Product

Presenters: Ankit Agrawal, Senior Director, Commercial Strategy, Curia Anish Parikh, Vice President, Drug Product Sales & Marketing, Curia Listen in as our experts discuss: The shortage of sterile manufacturing capacity within CDMOs given the Covid-19 pandemic The push to keep manufacturing within US borders The immense coordination to work with our clients to find a vaccine for Covid-19 The shortage of supplies (components, gowning, etc.)

View resource 0088AE5F-29AA-4BF7-826D-52FA93D463D0

Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

Contact Us
More from Curia

icons/content-types/video webinar

Antibody-Drug Conjugate (ADC) – From Bioassay Development to Linker-Payload Constructs

In this webinar, we will discuss select examples of Curia’s experience in the ADC discovery space and how some of these challenges are overcome.

icons/content-types/article article

Accelerating Therapies With Curia From Conception to Manufacturing

Partnering with a CDMO can help streamline drug development, and certain preparations can help ensure a successful collaboration. Scott Alderucci, Curia’s Director of Process Development, explores the advantages of partnering with a CDMO to navigat...